The radioimmunoassay was adopted to determine the levels of Interleukin 2 ( IL-2 ) , Interleukin 6 ( IL-6 ) , Interleukin 10 ( IL-10 ) and tumor necrosis factor ( TNF-alpha ) before and after treatment .